DelSiTech is an innovative drug delivery and development company that works with its partners to turn their active agents into novel, viable therapeutics.

DelSiTech is proudly based in Turku, Fin…
Joined February 2019
Today Visus announced worldwide exclusive agreements with Cella Therapeutics and @DelSiTech to expand our #ophthalmic drug portfolio with investigational therapies for #glaucoma and age-related macular degeneration. Read the full release➡️ bwnews.pr/2UyYGuo #opthotwitter
4
7
“In low- and middle-income countries, there are still tens of millions of #women who need support for family planning, and individuals at risk of #HIV infection in need of better #prevention measures,” @DelSiTech. 🙎🏽‍♀️#LMIC #biotech bit.ly/2KYkI2z
1
1
Replying to @DelSiTech
@DelSiTech received a grant from @gatesfoundation to support its development of #thermostabilisedvaccines that can be stored at room temperature #WorldHealthDay bit.ly/2XmWQcz
2
3
#RAReports Technologies designed to deliver more than one type of biologic product are 3DNA (@Genisphere ), DelSiTechTMSilica Matrix (@DelSiTech ), HEPtunetechnology (Caisson Biotech), PLEX Texhnology (PolyPid), V-Smart Platform (@LaurenSciences bit.ly/2GmIEdw
#RAReports #Novel #technologies for Delivery of Proteins, Antibodies & Nucleic Acids Market landscape of companies offering technologies for delivery of biotherapeutics, types of biologics delivered, routes of administration & impact on patient compliance bit.ly/2GmIEdw
#DelSiTech announce Licensing Agreement with Innovare for the Development of a Long Acting HIV Therapy bit.ly/2QC7A6Z #licensing #HIV #drugdelivery #pharma #drugdevelopment
2
1